Cargando…
Real-world efficacy of sequential nivolumab for metastatic renal cancer after first-line molecular targeting therapy
This study aimed to clarify the real-world efficacy of sequential nivolumab for treating metastatic renal cancer after first-line molecular targeting therapy. Patients were divided into two groups (2014–2016 and 2017–2020) according to the year when they started primary treatment with molecular targ...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371577/ https://www.ncbi.nlm.nih.gov/pubmed/35960101 http://dx.doi.org/10.1097/MD.0000000000029510 |